These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2822446)

  • 1. Down-regulation of hippocampal phencyclidine (PCP) receptors following amygdala kindling.
    Sircar R; Ludvig N; Zukin SR; Moshé SL
    Eur J Pharmacol; 1987 Sep; 141(1):167-8. PubMed ID: 2822446
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophilic affinity ligands for the phencyclidine (PCP) receptor.
    Lessor RA; Mattson MV; Rice KC; Jacobson AE
    NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571
    [No Abstract]   [Full Text] [Related]  

  • 3. A specific acylating agent for the [3H]phencyclidine receptors in rat brain.
    Rafferty MF; Mattson M; Jacobson AE; Rice KC
    FEBS Lett; 1985 Feb; 181(2):318-22. PubMed ID: 2982662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in rat brain [3H]-TCP binding following chronic phencyclidine administration.
    Massey BW; Wessinger WD
    Life Sci; 1990; 47(24):PL139-43. PubMed ID: 2176262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of polypeptides of the phencyclidine receptor of rat hippocampus by photoaffinity labeling with [3H]azidophencyclidine.
    Haring R; Kloog Y; Sokolovsky M
    Biochemistry; 1986 Feb; 25(3):612-20. PubMed ID: 3006764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of phencyclidine (PCP)-related compounds: correlations with 3H-PCP binding potency measured autoradiographically.
    Kozlowski MR; Browne RG; Vinick FJ
    Pharmacol Biochem Behav; 1986 Nov; 25(5):1051-8. PubMed ID: 3024183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced kainic acid binding in rat hippocampal formation after limbic kindling.
    Savage DD; Nadler JV; McNamara JO
    Brain Res; 1984 Dec; 323(1):128-31. PubMed ID: 6098330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific alkylating ligand for phencyclidine (PCP) receptors antagonizes PCP behavioral effects.
    Contreras PC; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    Eur J Pharmacol; 1985 May; 111(3):405-6. PubMed ID: 2990961
    [No Abstract]   [Full Text] [Related]  

  • 9. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metaphit on phencyclidine and serotonin2 receptors.
    Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
    Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disinhibitory effect of phencyclidine in the hippocampus in vitro: PCP receptors implicated.
    Bourne GW; Esplin B; Capek R
    Eur J Pharmacol; 1988 May; 150(1-2):67-74. PubMed ID: 2841144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An endogenous ligand of the brain sigma/PCP receptor antagonizes NMDA-induced neurotransmitter release.
    Zukin SR; Zukin RS; Vale W; Rivier J; Nichtenhauser R; Snell LD; Johnson KM
    Brain Res; 1987 Jul; 416(1):84-9. PubMed ID: 2887250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites.
    Roman FJ; Pascaud X; Duffy O; Vauche D; Martin B; Junien JL
    Eur J Pharmacol; 1989 Dec; 174(2-3):301-2. PubMed ID: 2560982
    [No Abstract]   [Full Text] [Related]  

  • 15. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays.
    Contreras PC; Quirion R; O'Donohue TL
    NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347
    [No Abstract]   [Full Text] [Related]  

  • 16. PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent.
    Tamminga CA; Tanimoto K; Kuo S; Chase TN; Contreras PC; Rice KC; Jackson AE; O'Donohue TL
    Synapse; 1987; 1(5):497-504. PubMed ID: 2850626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of phencyclidine analogs and phencyclidine/sigma ligands on vasoconstrictor response of rat mesenteric arteries induced by electrical field stimulation].
    Lu YF; Sun FY; Zhang AZ
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):293-5. PubMed ID: 1966572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and behavioral effects of sigma and PCP ligands.
    Contreras PC; Contreras ML; O'Donohue TL; Lair CC
    Synapse; 1988; 2(3):240-3. PubMed ID: 2850629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiohistochemical demonstration of NMDA/glycine-channel activation in rat hippocampus.
    Hosford DA; Bonhaus DW; McNamara JO
    Eur J Pharmacol; 1988 Jul; 151(3):501-3. PubMed ID: 2463927
    [No Abstract]   [Full Text] [Related]  

  • 20. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.